Korea to shorten screening period of phase 1 study

Published: 2010-07-22 06:57:00

Updated: 2010-07-22 06:57:00

The Korea Food and Drug Administration says it will simplify the screening procedures of local phase 1 clinical trials here as part of efforts to make this country attractive for multinational pharmaceutical companies.

To this end, the drug agency said that beginning January 2011, it will shor...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK